Virax Biolabs Group | 0.2317 +0.0010 +0.43% | ||
| VRAX | |||
| 高 0.2600 | 开 0.2308 | 量 18.26万股 | 总市值 172.00万 |
| 低 0.2306 | 换 2.46% | 额 4.45万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
Virax Biolabs Group(VRAX)
01-31 05:05
$Virax Biolabs Group(VRAX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-26-031750 Act: 34 Size: 5 MB 网页链接
Virax Biolabs Group(VRAX)
01-01 06:05
$Virax Biolabs Group(VRAX)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001193125-25-338385 Act: 33 Size: 298 KB 网页链接
Virax Biolabs Group(VRAX)
2025-12-31 19:05
$Virax Biolabs Group(VRAX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-25-003963 Act: 33 Size: 1 KB 网页链接
Virax Biolabs Group(VRAX)
2025-12-19 05:15
$Virax Biolabs Group(VRAX)$ F-3 Registration statement by foreign private issuers Accession Number: 0001193125-25-324805 Act: 33 Size: 653 KB 网页链接
Virax Biolabs Group(VRAX)
2025-12-18 23:15
$Virax Biolabs Group(VRAX)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001193125-25-323885 Act: 33 Size: 10 KB 网页链接
Virax Biolabs Group(VRAX)
2025-12-05 05:15
$Virax Biolabs Group(VRAX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-25-308079 Act: 34 Size: 1 MB 网页链接
Virax Biolabs Group(VRAX)
2025-12-03 05:45
$Virax Biolabs Group(VRAX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-25-305371 Act: 34 Size: 1 MB 网页链接
Virax Biolabs Group(VRAX)
2025-10-30 05:25
$Virax Biolabs Group(VRAX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001193125-25-256667 Act: 34 Size: 6 KB 网页链接
Virax Biolabs Group(VRAX)
2025-10-30 05:25
$Virax Biolabs Group(VRAX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001193125-25-256666 Act: 34 Size: 6 KB 网页链接
Virax Biolabs Group(VRAX)
2025-10-30 05:15
$Virax Biolabs Group(VRAX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001193125-25-256646 Act: 34 Size: 6 KB 网页链接
Virax Biolabs Group(VRAX)
2025-10-30 05:15
$Virax Biolabs Group(VRAX)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001193125-25-256640 Act: 34 Size: 6 KB 网页链接
Virax Biolabs Group(VRAX)
2025-07-31 04:15
$Virax Biolabs Group(VRAX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950170-25-100244 Act: 34 Size: 28 KB 网页链接
Virax Biolabs Group(VRAX)
2025-07-03 05:35
$Virax Biolabs Group(VRAX)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0000950170-25-093260 Act: 34 Size: 14 MB 网页链接
Virax Biolabs Group(VRAX)
2025-06-14 04:25
$Virax Biolabs Group(VRAX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950170-25-086224 Act: 34 Size: 24 KB 网页链接
Virax Biolabs Group(VRAX)
2025-03-18 20:15
$Virax Biolabs Group(VRAX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950170-25-040776 Act: 34 Size: 39 KB 网页链接
Virax Biolabs Group(VRAX)
2025-03-13 20:15
$Virax Biolabs Group(VRAX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950170-25-038350 Act: 34 Size: 40 KB 网页链接
Virax Biolabs Group(VRAX)
2025-03-05 20:55
$Virax Biolabs Group(VRAX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950170-25-033079 Act: 34 Size: 39 KB 网页链接
Virax Biolabs Group(VRAX)
2025-02-25 20:35
$Virax Biolabs Group(VRAX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950170-25-026073 Act: 34 Size: 41 KB 网页链接
Virax Biolabs Group(VRAX)
2025-01-31 06:35
$Virax Biolabs Group(VRAX)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0000950170-25-011148 Act: 33 Size: 493 KB 网页链接
Virax Biolabs Group(VRAX)
2024-12-23 21:55
$Virax Biolabs Group(VRAX)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0000950170-24-139294 Act: 34 Size: 50 KB 网页链接